TransCode Therapeutics Inc (NASDAQ:RNAZ) currently has a daily average trading volume of 1.72M but it saw 1055991 shares traded in last market. With a market cap of 1.75M USD, the company’s current market price of $2.52 came falling about -24.78 while comparing to the previous closing price of $3.35. In past 52 weeks, the stock remained buoying in the range of price level as high as $66.33 and as low as $2.66.
Taking a look at 20-day trading activity of TransCode Therapeutics Inc (RNAZ) gives us an average price of $8.44, while its current price level is -96.20% below from 52-week high level whereas it is -5.26% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $6.09 while that of 200 days or SMA-200 reads an average of $16.95. A closer look into the stock’s movement over the week reveals that its volatility is standing at 41.26% during that period while stretching the period over a month that decreases to 28.96%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.09 which implies that the stock is in neutral territory.
Over the week, RNAZ’s stock price is moving -73.11% down while it is -74.65% when we observe its performance for the past one month. Year-to-date it is -25.22% down and over the past year, the stock is showing a downside performance of -89.25%.
Currently, TransCode Therapeutics Inc’s total number of outstanding shares is 0.70M with 0.01% of that held by the insiders while 22.36% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -903.45% and return on equity (ROE) at -490.03%. Stock’s beta reads 1.11. Stock has a price to book (P/B) ratio of 0.80. Its return on asset (ROA) is -210.77% on average.
